麗珠集團(000513.SZ):上半年淨利同比增35.97%至10.05億元
格隆匯 8 月 25日丨麗珠集團(000513.SZ)披露2020年半年報,報告期,集團實現營業收入人民幣5095.24百萬元,相比上年同期的人民幣4939.07百萬元,同比增長3.16%;實現淨利潤人民幣1330.73百萬元,相比上年同期的人民幣834.53百萬元,同比增長59.46%;實現歸屬於本公司股東的淨利潤人民幣1004.74百萬元,相比上年同期的人民幣738.95百萬元,同比增長35.97%;若剔除非經常性損益項目收益,本公司2020年上半年主營業務實現的歸屬於本公司股東的淨利潤為人民幣834.56百萬元,相比上年同期的人民幣658.60百萬元,同比增長26.72%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.